ask="N/A"
ask_size="N/A"
average_daily_volume="409250"
bid="N/A"
bid_size="N/A"
book_value="8.16"
change="N/A"
change_from_200_day_moving_average="0.68"
change_from_50_day_moving_average="1.08"
change_from_52_week_high="-3.96"
change_From_52_week_low="9.01"
change_in_percent="N/A"
close="20.61"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.14"
ebitda="-16.56M"
eps_estimate_current_year="-1.32"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.11"
ex_dividend_date="N/A"
float_shares="21949000"
high="N/A"
high_52_weeks="24.57"
last_trade_date="2/13/2017"
last_trade_price="20.61"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="11.60"
market_capitalization="777.66M"
moving_average_200_day="19.93"
moving_average_50_day="19.53"
name="Retrophin
Inc."
notes="N/A"
one_year_target_price="34.67"
open="N/A"
pe_ratio="N/A"
peg_ratio="-0.80"
percent_change_from_200_day_moving_average="+3.42%"
percent_change_from_50_day_moving_average="+5.55%"
percent_change_from_52_week_high="-16.12%"
percent_change_from_52_week_low="+77.67%"
previous_close="20.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.53"
price_per_sales="6.14"
revenue="126.71M"
shares_outstanding="37732000"
short_ratio="13.94"
stock_exchange="NGM"
symbol="RTRX"
volume="0"
weeks_range_52="11.60 - 24.57"
